Latest Articles

  • Can an ARB be given to patients who have had angioedema on an ACE inhibitor?
    Prashant Sharma, MD and Vijaiganesh Nagarajan, MD
    Cleveland Clinic Journal of Medicine December 2013, 80 (12) 755-757; DOI: https://doi.org/10.3949/ccjm.80a.13041

    Proceed with caution. ARBs can also cause angioedema, but the benefit may outweigh the risk if the patient truly needs the drug.

  • The conundrum of explaining breast density to patients
    Erin N. Marcus, MD, MPH and Monica Yepes, MD
    Cleveland Clinic Journal of Medicine December 2013, 80 (12) 761-765; DOI: https://doi.org/10.3949/ccjm.80a.13026

    Several states have mandated that, after mammography, patients be informed if their breasts are dense. Explaining what this means is a challenge.

  • The FREEDOM trial (August 2013)
    Giovanni Saeed, MD, Rainer Gradaus, MD, PhD and Jörg Neuzner, MD, PhD
    Cleveland Clinic Journal of Medicine December 2013, 80 (12) 748-749; DOI: https://doi.org/10.3949/ccjm/80c.12001

    Readers comment on the FREEDOM trial (August 2013) and on electronic health records (July 2013).

  • Third universal definition of myocardial infarction: Update, caveats, differential diagnoses
    David M. Tehrani, MS and Arnold H. Seto, MD, MPA
    Cleveland Clinic Journal of Medicine December 2013, 80 (12) 777-786; DOI: https://doi.org/10.3949/ccjm.80a.12158

    Troponin levels are elevated in nearly everyone having a myocardial infarction—but also in many who are not. Hence, clinical judgment is needed.

  • Dense breasts and legislating medicine
    Nancy Ho, MD, Julie Kim, MD and Vinay Prasad, MD
    Cleveland Clinic Journal of Medicine December 2013, 80 (12) 768-770; DOI: https://doi.org/10.3949/ccjm.80a.13048

    As with accelerated drug approval, mandated disclosure of breast density has uncertain efficacy.

  • To Phil, adieu with many thanks and much gratitude
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2013, 80 (12) 745-746; DOI: https://doi.org/10.3949/ccjm.80b.12013

    Phil Canuto, the executive editor of the Cleveland Clinic Journal of Medicine for almost 20 years, is retiring.

  • Antiplatelet therapy to prevent recurrent stroke: Three good options
    Antiplatelet therapy to prevent recurrent stroke: Three good options
    Atizazul H. Mansoor, MD, Mohammad T. Mujtaba, MD and Brian Silver, MD
    Cleveland Clinic Journal of Medicine December 2013, 80 (12) 787-795; DOI: https://doi.org/10.3949/ccjm.80a.12149

    Aspirin, dipyridamole, and clopidogrel are important parts of therapy to prevent recurrent stroke of atherosclerotic origin.

  • Electronic health records (July 2013)
    Mark D. Bej, MD
    Cleveland Clinic Journal of Medicine December 2013, 80 (12) 754; DOI: https://doi.org/10.3949/ccjm/80c.12003

    Readers comment on the FREEDOM trial (August 2013) and on electronic health records (July 2013).

  • Ascites in a 42-year-old woman
    Debabrata Bandyopadhyay, MBBS, MD, Gursimran S. Kochhar, MD, Ibrahim Hanouneh, MD, Craig Nielsen, MD and David Barnes, MD
    Cleveland Clinic Journal of Medicine December 2013, 80 (12) 771-776; DOI: https://doi.org/10.3949/ccjm.80a.12118

    She has had worsening shortness of breath, leg edema, and ascites for 4 months. What is the cause?

  • In Reply: Renal risk stratification with the new oral anticoagulants (July 2013)
    Adewale Fawole, MD
    Cleveland Clinic Journal of Medicine November 2013, 80 (11) 734; DOI: https://doi.org/10.3949/ccjm.80c.11002

    Readers comment on the risk of bleeding with the new oral anticoagulants (July 2013) and on the signs of rheumatoid arthritis (May 2013).

Pages